Complete Filing Data
VANJIA CORP reported Net Income Loss of -$10.3 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean VANJIA CORP did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$10.3K | -$13.9K | $73.4K | -$11.4K | $1.8K | -$42.3K | -$41.1K | -$17.5K | -$8.9K | -$6.1K | -$23.1K | -$12.9K | -$8.4K | -$5.6K | -$3.9K |
| General And Administrative Expense | $10.3K | $13.9K | $9.3K | $11.4K | $32.4K | $42.8K | $26.6K | $24.6K | $8.9K | $9.9K | $23.1K | $12.9K | $8.4K | $5.6K | $3.9K |
| Operating Income Loss | -$10.3K | -$13.9K | $73.4K | -$11.4K | $1.8K | -$42.3K | -$3.6K | -$17.5K | -$8.9K | -$9.9K | -$8.4K | -$5.6K | |||
| Income Loss From Continuing Operations Per Basic And Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Domestic | -$17.5K | -$8.9K | |||||||||||||
| Revenues | $82.7K | $34.2K | $500.00 | $23.0K | $7.1K | ||||||||||
| Gain Loss On Sale Of Properties Before Applicable Income Taxes | -$8.9K | -$6.1K | -$23.1K | ||||||||||||
| Income Loss From Continuing Operations | -$9.9K | -$23.1K | |||||||||||||
| Net Income Loss1 | -$8.4K | -$5.6K | |||||||||||||
| Impairment Of Investments | $37.5K | ||||||||||||||
| Net Income Loss3 | |||||||||||||||
| Net Income Loss2 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$450.00 | -$5.2K | -$450.00 | -$1.7K | $41.3K | -$9.5K | -$1.2K | $45.5K | $45.5K | -$1.6K | -$2.3K | -$5.6K | $2.8K | -$12.0K | -$590.00 | -$2.9K | -$31.4K | -$5.4K | -$4.0K | -$10.7K | -$24.4K | -$4.3K | -$1.2K | -$1.2K | -$1.5K | -$107.00 | -$1.3K | -$1.3K | -$48.00 | -$2.2K | -$2.2K | -$675.00 | -$4.2K | -$6.8K | -$671.00 | -$800.00 | -$2.8K | -$976.00 | -$1.5K | -$1.2K | -$2.2K | -$3.9K |
| General And Administrative Expense | $450.00 | $5.2K | $450.00 | $1.7K | $8.7K | $9.5K | $1.2K | $4.5K | $4.5K | $1.6K | $2.3K | $5.6K | $5.6K | $12.0K | $5.2K | $2.9K | $31.4K | $5.4K | $4.5K | $11.2K | $8.5K | $8.2K | $1.2K | $1.2K | $1.5K | $1.5K | $1.8K | $1.8K | $1.0K | $2.2K | $2.2K | $675.00 | $4.2K | $6.8K | $671.00 | $800.00 | $2.8K | $976.00 | $1.5K | $1.2K | $2.2K | |
| Operating Income Loss | -$450.00 | -$5.2K | -$450.00 | -$1.7K | $41.3K | -$9.5K | -$1.2K | $45.5K | $45.5K | -$1.6K | -$2.3K | -$5.6K | $2.8K | -$12.0K | -$590.00 | -$2.9K | -$31.4K | -$5.4K | -$4.0K | -$10.7K | $13.1K | -$4.3K | -$1.2K | -$1.2K | -$1.5K | $1.8K | ||||||||||||||||
| Income Loss From Continuing Operations Per Basic And Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Domestic | -$450.00 | -$5.2K | -$450.00 | -$1.7K | $41.3K | -$9.5K | -$1.2K | $45.5K | $45.5K | -$2.3K | -$5.6K | -$12.0K | -$590.00 | -$2.9K | -$31.4K | -$5.4K | -$4.0K | -$10.7K | -$24.4K | -$1.2K | -$1.2K | |||||||||||||||||||||
| Revenues | $0.00 | $50.0K | $50.0K | $50.0K | $8.4K | $4.6K | $500.00 | $500.00 | $21.6K | $3.9K | ||||||||||||||||||||||||||||||||
| Gain Loss On Sale Of Properties Before Applicable Income Taxes | -$4.3K | -$1.2K | -$1.5K | -$107.00 | -$1.3K | -$1.3K | -$48.00 | -$2.2K | -$675.00 | |||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations | -$4.3K | -$1.2K | -$1.5K | -$1.5K | -$1.8K | $1.0K | -$2.2K | -$675.00 | ||||||||||||||||||||||||||||||||||
| Net Income Loss1 | $450.00 | $9.5K | $67.6K | -$671.00 | -$976.00 | |||||||||||||||||||||||||||||||||||||
| Impairment Of Investments | $37.5K | |||||||||||||||||||||||||||||||||||||||||
| Net Income Loss3 | -$1.7K | -$1.2K | ||||||||||||||||||||||||||||||||||||||||
| Net Income Loss2 | $41.3K | $69.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $67.3K | $77.6K | $91.6K | $760.1K | $771.5K | $769.8K | $812.1K | $111.2K | $16.3K | $25.1K | $31.2K | $54.3K | $67.2K | $75.5K | $31.1K |
| Cash And Cash Equivalents At Carrying Value | $62.6K | $72.9K | $22.6K | $18.1K | $29.5K | $27.8K | $70.1K | $25.7K | $87.00 | $148.00 | $6.2K | $29.3K | $42.2K | $50.5K | $10.0K |
| Liabilities And Stockholders Equity | $67.3K | $77.6K | $833.6K | $760.1K | $771.5K | $769.8K | $812.1K | $63.2K | $25.1K | $25.1K | $31.2K | $54.3K | $67.2K | $75.5K | $35.0K |
| Assets | $67.3K | $77.6K | $833.6K | $760.1K | $771.5K | $769.8K | $812.1K | $63.2K | $25.1K | $25.1K | $31.2K | $54.3K | $67.2K | $75.5K | $35.0K |
| Common Stock Value | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $113.0K | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $350.00 |
| Assets Current | $70.1K | $25.7K | $87.00 | $148.00 | $6.2K | $29.3K | $42.2K | $50.5K | $10.0K | ||||||
| Cash | $62.6K | $72.9K | $22.6K | $18.1K | $29.5K | $27.8K | $70.1K | $25.7K | $87.00 | $148.00 | $6.2K | $29.3K | $42.2K | $50.5K | $10.0K |
| Retained Earnings Accumulated Deficit | -$130.1K | -$119.8K | -$105.8K | -$179.3K | -$167.9K | -$169.6K | -$127.3K | -$86.2K | -$68.7K | -$53.8K | -$30.7K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $62.6K | $72.9K | $22.6K | $18.1K | $29.5K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$10.3K | $50.3K | $4.4K | -$11.4K | $1.8K | -$42.3K | |||||||||
| Cash Period Increase Decrease | -$61.00 | -$6.1K | -$23.1K | -$12.9K | -$8.4K | ||||||||||
| Net Change In Cash | -$8.4K | $40.5K | $10.0K | ||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$42.3K | $44.4K | $25.6K | -$61.00 | |||||||||||
| Accounts Receivable Net | $4.7K | $4.7K | $69.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Issuance Of Common Stock In Exchange Of Real Property | $25.0K | ||||||||||||||
| Accounts Receivable Net Current | $0.00 | $0.00 | |||||||||||||
| Liabilities Current | $8.8K | $3.9K | |||||||||||||
| Inventory Real Estate | $25.0K | ||||||||||||||
| Common Stock Share Subscribed But Unissued Subscriptions Receivable | $48.0K | ||||||||||||||
| Common Stock Value Outstanding | |||||||||||||||
| Common Stock Share Issued And Outstanding | |||||||||||||||
| Gain Loss On Investments | $37.5K | ||||||||||||||
| Accrued Liabilities For Commissions Expense And Taxes | $3.9K | ||||||||||||||
| Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock | |||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Stockholders Equity Note Subscriptions Receivable |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $71.5K | $72.0K | $77.2K | $863.6K | $863.6K | $824.0K | $901.6K | $902.8K | $833.6K | $762.1K | $763.7K | $766.0K | $759.9K | $751.1K | $769.2K | $772.4K | $775.3K | $806.7K | $814.2K | $770.2K | $780.8K | $53.7K | -$15.1K | $18.4K | $25.0K | $25.2K | $26.5K | $31.2K | $45.2K | $47.4K | $53.6K | $55.5K | $59.7K | $66.5K | $71.0K | $71.8K | $27.7K | $28.9K | $31.1K | $31.1K | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $66.8K | $67.2K | $72.4K | $71.6K | $73.3K | $82.0K | $17.2K | $12.4K | $13.6K | $20.1K | $21.7K | $24.0K | $17.9K | $15.1K | $27.2K | $30.4K | $33.3K | $64.7K | $72.2K | $28.2K | $38.8K | $16.2K | $187.00 | $96.00 | $41.00 | $199.00 | $1.5K | $6.2K | $20.2K | $22.4K | $28.6K | $30.5K | $34.7K | $41.5K | $46.0K | $46.8K | $2.7K | $3.9K | $10.0K | $10.0K | ||||||||||
| Liabilities And Stockholders Equity | $71.5K | $72.0K | $77.2K | $863.6K | $865.3K | $824.0K | $828.2K | $829.4K | $805.6K | $762.1K | $763.7K | $766.0K | $759.9K | $757.1K | $769.2K | $772.4K | $775.3K | $806.7K | $814.2K | $770.2K | $780.8K | $53.7K | $25.2K | $25.1K | $25.0K | $25.2K | $26.5K | $31.2K | $45.2K | $47.4K | $53.6K | $55.5K | $59.7K | $66.5K | $71.0K | $71.8K | $27.7K | $28.9K | $35.0K | $35.0K | ||||||||||
| Assets | $71.5K | $72.0K | $77.2K | $863.6K | $865.3K | $824.0K | $828.2K | $829.4K | $805.6K | $762.1K | $763.7K | $766.0K | $759.9K | $757.1K | $769.2K | $772.4K | $775.3K | $806.7K | $814.2K | $770.2K | $780.8K | $53.7K | $25.2K | $25.1K | $25.0K | $25.2K | $26.5K | $31.2K | $45.2K | $47.4K | $53.6K | $55.5K | $59.7K | $66.5K | $71.0K | $71.8K | $27.7K | $28.9K | $35.0K | $35.0K | ||||||||||
| Common Stock Value | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $855.0K | $855.0K | $855.0K | $855.0K | $50.0K | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $350.00 | |||||||||||||
| Assets Current | $77.2K | $77.6K | $82.0K | $91.6K | $86.2K | $63.6K | $18.1K | $20.1K | $21.7K | $24.0K | $29.5K | $17.9K | $15.1K | $27.2K | $27.8K | $30.4K | $33.3K | $64.7K | $72.2K | $28.2K | $38.8K | $16.2K | $187.00 | $96.00 | $41.00 | $199.00 | $1.5K | $6.2K | $20.2K | $22.4K | $28.6K | $30.5K | $34.7K | $41.5K | $46.0K | $46.8K | $2.7K | $3.9K | $10.0K | $10.0K | ||||||||||
| Cash | $66.8K | $67.2K | $72.4K | $71.6K | $73.3K | $82.0K | $17.2K | $12.4K | $13.6K | $20.1K | $21.7K | $24.0K | $17.9K | $15.1K | $27.2K | $30.4K | $33.3K | $64.7K | $72.2K | $28.2K | $38.8K | $16.2K | $187.00 | $96.00 | $41.00 | $199.00 | $1.5K | $6.2K | $20.2K | $22.4K | $28.6K | $30.5K | $34.7K | $41.5K | $46.0K | $46.8K | $2.7K | $3.9K | $10.0K | $10.0K | ||||||||||
| Retained Earnings Accumulated Deficit | -$125.9K | -$125.4K | -$120.2K | -$75.8K | -$74.1K | -$115.4K | -$111.2K | -$110.0K | -$133.8K | -$177.3K | -$175.7K | -$173.4K | -$179.5K | -$182.3K | -$170.2K | -$167.0K | -$164.1K | -$132.7K | -$125.2K | -$121.2K | -$110.6K | -$80.7K | -$69.9K | $65.1K | $65.1K | -$60.0K | -$59.9K | -$59.8K | -$58.5K | -$53.8K | -$39.8K | -$37.6K | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $71.5K | $72.0K | $72.4K | $71.6K | $73.3K | $82.0K | $17.2K | $12.4K | $13.6K | $20.1K | $21.7K | $24.0K | ||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$450.00 | $68.4K | -$45.5K | -$5.6K | -$590.00 | -$5.4K | ||||||||||||||||||||||||||||||||||||||||||||
| Cash Period Increase Decrease | $100.00 | -$107.00 | -$48.00 | -$675.00 | -$671.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Net Change In Cash | -$671.00 | -$976.00 | -$6.1K | |||||||||||||||||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$5.4K | $13.1K | $100.00 | |||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Receivable Net | $4.7K | $4.7K | $4.7K | |||||||||||||||||||||||||||||||||||||||||||||||
| Issuance Of Common Stock In Exchange Of Real Property | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Receivable Net Current | $50.0K | $50.0K | $69.0K | $69.0K | $75.0K | $50.0K | $0.00 | |||||||||||||||||||||||||||||||||||||||||||
| Liabilities Current | $6.7K | $3.9K | $3.9K | |||||||||||||||||||||||||||||||||||||||||||||||
| Inventory Real Estate | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |||||||||||||||||||||||||||||||||||||||||||||
| Common Stock Share Subscribed But Unissued Subscriptions Receivable | $48.0K | $48.0K | ||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock Value Outstanding | $600.00 | $350.00 | $350.00 | $350.00 | ||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock Share Issued And Outstanding | $3.5M | $3.5M | $3.5M | $3.5M | ||||||||||||||||||||||||||||||||||||||||||||||
| Gain Loss On Investments | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued Liabilities For Commissions Expense And Taxes | $3.9K | $3.9K | ||||||||||||||||||||||||||||||||||||||||||||||||
| Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock | $10.1K | $8.8K | ||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock Value | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders Equity Note Subscriptions Receivable | -$50.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$10.3K | $50.3K | $4.4K | -$11.4K | $1.8K | -$42.3K | -$3.6K | -$9.4K | -$61.00 | -$6.1K | -$23.1K | -$12.9K | -$8.4K | -$9.5K | |
| Net Cash Provided By Used In Financing Activities | $48.0K | $35.0K | $50.0K | $10.0K | |||||||||||
| Proceeds From Issuance Of Common Stock | $48.0K | $35.0K | $50.0K | $10.0K | |||||||||||
| Increase Decrease In Accrued Liabilities | $8.1K | $8.8K | -$6.1K | -$3.9K | |||||||||||
| Increase Decrease In Accounts Receivable | -$64.3K | $69.0K | |||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$3.9K | $3.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$450.00 | $68.4K | -$45.5K | -$5.6K | -$590.00 | -$5.4K | $13.1K | $100.00 | -$107.00 | -$48.00 | -$675.00 | -$671.00 | -$976.00 | -$6.1K |
| Net Cash Provided By Used In Financing Activities | ||||||||||||||
| Proceeds From Issuance Of Common Stock | ||||||||||||||
| Increase Decrease In Accrued Liabilities | $1.3K | -$3.9K | ||||||||||||
| Increase Decrease In Accounts Receivable | -$58.9K | |||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Share Outstanding Basic And Diluted | 30.0M | 30.0M | 30.0M | 257.2M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 4.9M | 3.5M | ||||
| Common Stock Shares Authorized | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Issued | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 1.13B | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Shares Outstanding | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 1.13B | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 3.5M |
| Earnings Per Share Basic And Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Weighted Average Number Of Shares Issued Basic | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | ||||||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Preferred Stock Shares Issued And Outstanding | |||||||||||||||
| Shares Issued | 67.2K | 75.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Share Outstanding Basic And Diluted | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 1.21B | 118.6M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 3.9M | 3.5M | 3.5M | ||||||||||||||
| Common Stock Shares Authorized | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | 10.00B | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Shares Authorized | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | 8.89B | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Common Stock Shares Issued | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 8.55B | 8.55B | 8.55B | 8.55B | 500.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Common Stock Shares Outstanding | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 8.55B | 8.55B | 8.55B | 8.55B | 500.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 3.5M | 6.0M | 6.0M | 6.0M | |||||||||
| Earnings Per Share Basic And Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||
| Weighted Average Number Of Shares Issued Basic | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | |||||||||||||||||||||||||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||
| Preferred Stock Shares Issued And Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||||||||||||||||
| Shares Issued |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $194.4K | $194.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $34.7K |
| Land Held For Investment | $0.00 | $0.00 | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $37.5K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| Ending | $42.2K | $50.5K | $10.0K | ||||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $17.8K | -$9.5K | -$3.9K | ||||||||||||
| Net Loss | -$5.6K | -$3.9K | |||||||||||||
| Other Income | $3.8K | ||||||||||||||
| Beginning | $50.5K | $10.0K | |||||||||||||
| Stock Issued During Period Value Acquisitions | $742.0K | $12.5K | |||||||||||||
| SEC Schedule III Real Estate Investment Property Net | |||||||||||||||
| Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation | -$68.7K | -$59.9K | |||||||||||||
| Deficit Accumulated During Development Stage | |||||||||||||||
| Stock Issued During Period Value Other | $16.9K | $50.0K | |||||||||||||
| Due To Officers Or Stockholders Current | $8.8K | ||||||||||||||
| Basic And Diluted | $6.0M | $4.9M | |||||||||||||
| Stock Issued During Period Value New Issues1 | $15.0K | ||||||||||||||
| Stock Issued During Period Value New Issues | $20.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q1 2018 | Q3 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q2 2012 | Q1 2012 | Q4 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $194.4K | $194.4K | $194.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $936.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $84.4K | $34.7K | $34.7K | $34.7K | |||
| Land Held For Investment | $0.00 | $0.00 | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $742.0K | $37.5K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | ||||||||||
| Ending | $41.5K | $49.6K | $3.9K | ||||||||||||||||||||||||||||||||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $31.4K | $30.7K | $29.5K | $25.3K | -$18.5K | -$14.0K | -$13.2K | -$6.1K | -$3.9K | -$3.9K | |||||||||||||||||||||||||||||||||
| Net Loss | -$976.00 | -$2.2K | |||||||||||||||||||||||||||||||||||||||||
| Other Income | $1.4K | $500.00 | $500.00 | $1.0K | |||||||||||||||||||||||||||||||||||||||
| Beginning | $42.2K | $50.5K | $10.0K | ||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Acquisitions | $742.0K | ||||||||||||||||||||||||||||||||||||||||||
| SEC Schedule III Real Estate Investment Property Net | $25.0K | $25.0K | $25.0K | ||||||||||||||||||||||||||||||||||||||||
| Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation | -$66.6K | ||||||||||||||||||||||||||||||||||||||||||
| Deficit Accumulated During Development Stage | -$7.3K | -$3.9K | |||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Other | |||||||||||||||||||||||||||||||||||||||||||
| Due To Officers Or Stockholders Current | $6.7K | ||||||||||||||||||||||||||||||||||||||||||
| Basic And Diluted | |||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues1 | |||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.